Journey Medical Corporation Share Price & Technical Analysis
DERM · $5.98 (-0.66%)
Healthcare / Drug Manufacturers - Specialty & Generic
$5.98
-0.66%
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat seve…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-5% return in Jun, 22% avg return in past 3 year Jun month.
-7% return in 2026, 62% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 9% | -2% | -43% | 11% | 24% | -5% | – | – | – | – | – | – | -7% |
| 25 | 15% | 22% | 4% | 25% | 9% | -12% | 3% | -1% | 0% | 13% | 0% | -4% | 73% |
| 24 | -17% | -15% | -7% | 6% | 5% | 44% | 4% | -9% | 14% | 2% | 0% | -32% | -6% |
| 23 | 10% | -29% | -6% | 6% | -33% | 33% | 12% | 11% | 35% | 21% | 23% | 38% | 120% |
| 22 | 0% | -2% | -9% | -22% | -5% | -5% | 3% | -8% | -29% | -15% | -18% | 6% | -106% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$162.87M
P/E ratio
—
52W high
$9.55
52W low
$4.31
Volume
64,083
Beta
1.03
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Journey Medical Corporation share price today?
- Journey Medical Corporation (DERM) last traded around $5.98 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DERM have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DERM. Download the app for real-time alerts.
- How can I analyze Journey Medical Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.